Tag: Biotech

Between now and 2030, biologic products worth US $170 billion will lose patent protection globally, writes Dr Cyrus Karkaria, President – Biotechnology, Lupin Limited

Bhubneshwar based startup, ProCyto Labs aims to bloom into a pioneering life-sciences company with its biotech and healthtech product offerings

The current issue discusses both approved and pending bills related to bioscience sector in the Parliament. It features the power-packed interviews with Krishna Mohan Puvvada, Vice President, Novozymes-South Asia; Dr Radha Rangarajan, Director, Central Drug Research Institute; Vikram Thaploo, CEO-Telehealth, Apollo Hospitals; and Vaibhav Tewari, Co-founder & CEO, Portea Medical.

The two countries to hold comprehensive talks between delegations comprising academia, R&D Institutes and Industry in the field of S&T and biotechnology

These bioreactors are user-friendly and automated, making the operational process extremely easy

This edition showcases the top 10 biotechnologies to watch out for in 2023. Insightful interviews of Piyush Sohani, Managing Director, Sistema.bio India and Dr Rachna Dave, CEO & Founder of MicroGO.

According to GlobalData’s Pharma Intelligence Center Deals database, the US biotechs saw 48% or $1.1 billion more in innovator drug venture financing, reaching a total deal value of $3.2 billion in 2023

India's biotechnology industry crossed US$ 80.12 billion in FY 2022-23, recording 14% growth over previous year. Can it register fourfold increase in its revenue over the period of next 8 years and how?

This edition tracks the latest scenario in Indian CRO industry and analyzes whether India can become a hotspot for clinical trials. Key highlights include Expert Insights by Dr Cyrus Karkaria, President- Biotechnology, Lupin and Zoya Brar, Founder, CORE Diagnostics.

This transformative shift in global market dynamics is fueled by the rapid growth of biologic sales